• G00113

• 2.4.1.92
• 2.4.3.8

RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
4s:n-acetyl
5b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
6s:n-acetyl
LIN
1:1o(4+1)2d
2:2o(3+2)3d
3:3d(5+1)4n
4:3o(8+2)5d
5:5d(5+1)6n

• Yuki N et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci. 1995 May;130:(1):112-6. doi: 10.1016/0022-510x(95)00045-4. PMID: 7544402.

• Yamaguchi H et al. Cell-surface antigens of melanoma recognized by human monoclonal antibodies. Proc Natl Acad Sci U S A. 1987 Apr;84:(8):2416-20. doi: 10.1073/pnas.84.8.2416. PMID: 3031684.

• Watarai S et al. Production of monoclonal antibodies specific for ganglioside GD3. J Biochem. 1991 Dec;110:(6):889-95. doi: 10.1093/oxfordjournals.jbchem.a123685. PMID: 1724444.

• Kawashima I et al. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J Biochem. 1993 Aug;114:(2):186-93. doi: 10.1093/oxfordjournals.jbchem.a124153. PMID: 8262898.

• Willison HJ et al. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain. 2004 Mar;127:(Pt 3):680-91. doi: 10.1093/brain/awh083. PMID: 14960498.

• Brodin T et al. Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside. Biochim Biophys Acta. 1985 Dec 4;837:(3):349-53. doi: 10.1016/0005-2760(85)90059-1. PMID: 3840699.

• Welte B et al. Expression of GD3 disialoganglioside antigen on peripheral T-lymphocytes in patients with disseminated malignant melanoma. Exp Dermatol. 1997 Apr;6:(2):64-9. doi: 10.1111/j.1600-0625.1997.tb00148.x. PMID: 9209886.

• Tai T et al. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3. Arch Biochem Biophys. 1988 Jan;260:(1):51-5. doi: 10.1016/0003-9861(88)90423-7. PMID: 2449128.

• Hedberg KM et al. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains. Neuropathol Appl Neurobiol. 2001 Dec;27:(6):451-64. doi: 10.1046/j.1365-2990.2001.00353.x. PMID: 11903928.

• Cheresh DA et al. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J Cell Biol. 1986 Mar;102:(3):688-96. doi: 10.1083/jcb.102.3.688. PMID: 3005335.

• Pukel CS et al. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med. 1982 Apr 1;155:(4):1133-47. doi: 10.1084/jem.155.4.1133. PMID: 7061953.

• Ravindranath MH et al. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5;324:(1):154-65. doi: 10.1016/j.bbrc.2004.09.029. PMID: 15464996.

• Hildebrandt H et al. Antigen binding of antiganglioside antibodies in vitro is strongly influenced by the ganglioside composition of the sample. FEBS Lett. 1996 Jun 10;388:(1):29-33. doi: 10.1016/0014-5793(96)00503-0. PMID: 8654583.

• Zenita K et al. Northern hybridization analysis of VH gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages. J Immunol. 1990 Jun 1;144:(11):4442-51. PMID: 2111348.

• Werkmeister JA et al. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3. Cancer Res. 1987 Jan 1;47:(1):225-30. PMID: 3791209.

• Goodyear CS et al. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest. 1999 Sep;104:(6):697-708. doi: 10.1172/JCI6837. PMID: 10491405.

• Furukawa K et al. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Res. 1989 Jan 1;49:(1):191-6. PMID: 2908845.

• Cheresh DA et al. Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci U S A. 1984 Sep;81:(18):5767-71. doi: 10.1073/pnas.81.18.5767. PMID: 6385004.

• Boffey J et al. Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. J Neuroimmunol. 2004 Jul;152:(1-2):98-111. doi: 10.1016/j.jneuroim.2004.04.002. PMID: 15223242.

• Kotani M et al. Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res. 1995 Nov 27;700:(1-2):40-58. doi: 10.1016/0006-8993(95)00923-e. PMID: 8624728.

• Townson K et al. Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology. 2007 Nov;17:(11):1156-66. doi: 10.1093/glycob/cwm095. PMID: 17855742.

• Tai T et al. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2. J Biochem. 1988 Apr;103:(4):682-7. doi: 10.1093/oxfordjournals.jbchem.a122329. PMID: 3170507.

• Kawashima I et al. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 1996 Sep 2;732:(1-2):75-86. doi: 10.1016/0006-8993(96)00493-3. PMID: 8891271.

• Cheresh DA et al. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis. Cancer Res. 1986 Oct;46:(10):5112-8. PMID: 3019521.

• Boffey J et al. Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol. 2005 Aug;165:(1-2):92-103. doi: 10.1016/j.jneuroim.2005.04.011. PMID: 15967512.

• Kotani M et al. Immunohistochemical localization of minor gangliosides in the rat central nervous system. Glycobiology. 1994 Dec;4:(6):855-65. doi: 10.1093/glycob/4.6.855. PMID: 7734848.

• Ozawa H et al. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim Biophys Acta. 1992 Jan 24;1123:(2):184-90. doi: 10.1016/0005-2760(92)90110-h. PMID: 1371229.

• Thurin J et al. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Cancer Res. 1987 Mar 1;47:(5):1229-33. PMID: 3815333.

• Fukuta S et al. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides. J Biol Chem. 1987 Apr 5;262:(10):4800-3. PMID: 2435716.